TRGNF
Price:
$1
Market Cap:
$121.73M
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative head and neck cancers; TG4001, a therapeutic vaccine, which is in phase II clinical trial for the treatment of HPV-positive cancers; TG6002, an oncolytic virus that is in phase I/IIa clinical trial for the treatment of various solid tumors, such as gastrointestinal adenocarcinoma comprising stomach, pancreas, and colon; and BT-001, an oncolytic virus, whic...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
TRGNF
According to Transgene S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 135.53M. This represents a change of 28.03% compared to the average of 105.86M of the last 4 quarters.
The mean historical Enterprise Value of Transgene S.A. over the last ten years is 160.73M. The current 135.53M Enterprise Value has changed 8.33% with respect to the historical average. Over the past ten years (40 quarters), TRGNF's Enterprise Value was at its highest in in the December 2009 quarter at 395.07M. The Enterprise Value was at its lowest in in the January 2006 quarter at 0.
Average
160.73M
Median
152.53M
Minimum
73.06M
Maximum
229.36M
Discovering the peaks and valleys of Transgene S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.38%
Maximum Annual Enterprise Value = 229.36M
Minimum Annual Increase = -56.13%
Minimum Annual Enterprise Value = 73.06M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 73.06M | -41.38% |
| 2023 | 124.63M | -23.55% |
| 2022 | 163.02M | -28.92% |
| 2021 | 229.36M | 66.38% |
| 2020 | 137.86M | -2.95% |
| 2019 | 142.04M | -29.47% |
| 2018 | 201.38M | -7.80% |
| 2017 | 218.42M | 16.28% |
| 2016 | 187.84M | 44.82% |
| 2015 | 129.71M | -56.13% |
The current Enterprise Value of Transgene S.A. (TRGNF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
120.24M
5-year avg
145.59M
10-year avg
160.73M
Transgene S.A.’s Enterprise Value is less than Hansa Biopharma AB (publ) (3.51B), less than Silence Therapeutics plc (242.52M), less than Cellectis S.A. (379.61M), less than Immutep Limited (316.92M), less than Genfit S.A. (258.87M), greater than hVIVO plc (3.77M), less than Santhera Pharmaceuticals Holding AG (217.29M), less than Mayne Pharma Group Limited (242.23M), less than Probi AB (publ) (3.70B), less than Oryzon Genomics S.A. (236.52M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.51B | $246.65M | |
| 242.52M | $255.06M | |
| 379.61M | $325.46M | |
| 316.92M | $264.95M | |
| 258.87M | $206.16M | |
| 3.77M | $164.93M | |
| 217.29M | $172.71M | |
| 242.23M | $191.74M | |
| 3.70B | $286.93M | |
| 236.52M | $264.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transgene S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Transgene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Transgene S.A.'s Enterprise Value?
What is the highest Enterprise Value for Transgene S.A. (TRGNF)?
What is the 3-year average Enterprise Value for Transgene S.A. (TRGNF)?
What is the 5-year average Enterprise Value for Transgene S.A. (TRGNF)?
How does the current Enterprise Value for Transgene S.A. (TRGNF) compare to its historical average?